{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:46:48Z","timestamp":1793249208625,"version":"4.5.0"},"reference-count":56,"publisher":"Siapec Servizi Srl","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologica"],"DOI":"10.32074\/1591-951x-1243","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T11:47:36Z","timestamp":1766836056000},"page":"486-495","source":"Crossref","is-referenced-by-count":2,"title":["MTAP in small biopsy samples of pancreatic lesions: a potential diagnostic biomarker. Immunohistochemical, fluorescence in situ hybridization and molecular analysis"],"prefix":"10.32074","volume":"117","author":[{"given":"Stefano","family":"Luc\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Salzillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Masola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"De Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Porpora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Conzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Savarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Sirica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immacolata","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Clery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Zito Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Montella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21774","published-online":{"date-parts":[[2025,12]]},"reference":[{"key":"10.32074\/1591-951X-1243_ref1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer Statistics. CA: Cancer J Clin. 2017;67(1):7-30. https:\/\/doi.org\/10.3322\/caac.21387","DOI":"10.3322\/caac.21387"},{"key":"10.32074\/1591-951X-1243_ref2","doi-asserted-by":"crossref","unstructured":"Chiaravalli M, Reni M, O\u2019Reilly EM. Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies. Cancer Treat Rev. 2017;60:32-43. https:\/\/doi.org\/10.1016\/j.ctrv.2017.08.007","DOI":"10.1016\/j.ctrv.2017.08.007"},{"key":"10.32074\/1591-951X-1243_ref3","doi-asserted-by":"crossref","unstructured":"Rawla P, Sunkara T, Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019;10(1):10-27. https:\/\/doi.org\/10.14740\/wjon1166","DOI":"10.14740\/wjon1166"},{"key":"10.32074\/1591-951X-1243_ref4","doi-asserted-by":"crossref","unstructured":"Distler M, Aust D, Weitz J, et al. Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN. Biomed Res Int. 2014;2014:474905. https:\/\/doi.org\/10.1155\/2014\/474905","DOI":"10.1155\/2014\/474905"},{"key":"10.32074\/1591-951X-1243_ref5","doi-asserted-by":"crossref","unstructured":"Nakaoka K, Ohno E, Kawabe N, et al. Current Status of the Diagnosis of Early-Stage Pancreatic Ductal Adenocarcinoma. Diagnostics. 2023;13(2):215. https:\/\/doi.org\/10.3390\/diagnostics13020215","DOI":"10.3390\/diagnostics13020215"},{"key":"10.32074\/1591-951X-1243_ref6","doi-asserted-by":"crossref","unstructured":"Adsay NV, Bandyopadhyay S, Basturk O, et al. Chronic pancreatitis or pancreatic ductal adenocarcinoma? Semin Diagn Pathol. 2004;21(4):268-276. https:\/\/doi.org\/10.1053\/j.semdp.2005.08.002","DOI":"10.1053\/j.semdp.2005.08.002"},{"key":"10.32074\/1591-951X-1243_ref7","doi-asserted-by":"crossref","unstructured":"Valentini AM, Savino MT, Donghia R, et al. Role of Immunohistochemistry in Suspected Pancreatic Ductal Adenocarcinoma: A Prospective Study on Fine Needle Aspiration Biopsies. Pancreas. 2022;51(10):1372-1375. https:\/\/doi.org\/10.1097\/MPA.0000000000002188","DOI":"10.1097\/MPA.0000000000002188"},{"key":"10.32074\/1591-951X-1243_ref8","doi-asserted-by":"crossref","unstructured":"Wang JD, Jin K, Chen XY, et al. Clinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis. Oncotarget. 2017;8(10):16704-16711. https:\/\/doi.org\/10.18632\/oncotarget.14335","DOI":"10.18632\/oncotarget.14335"},{"key":"10.32074\/1591-951X-1243_ref9","doi-asserted-by":"crossref","unstructured":"Sweeney J, Rao R, Margolskee E, et al. Immunohistochemical staining for S100P, SMAD4, and IMP3 on cell block preparations is sensitive and highly specific for pancreatic ductal adenocarcinoma. J Am Soc Cytopathol. 2018;7(6):318-323. https:\/\/doi.org\/10.1016\/j.jasc.2018.07.002","DOI":"10.1016\/j.jasc.2018.07.002"},{"key":"10.32074\/1591-951X-1243_ref10","doi-asserted-by":"crossref","unstructured":"Qian Y, Gong Y, Fan Z, et al. Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma. J Hematol Oncol. 2020;13(1):130. https:\/\/doi.org\/10.1186\/s13045-020-00958-3","DOI":"10.1186\/s13045-020-00958-3"},{"key":"10.32074\/1591-951X-1243_ref11","doi-asserted-by":"crossref","unstructured":"Bertoli C, Skotheim JM, de Bruin RA. Control of cell cycle transcription during G1 and S phases. Nat Rev Mol Cell Biol. 2013;14(8):518-528. https:\/\/doi.org\/10.1038\/nrm3629","DOI":"10.1038\/nrm3629"},{"key":"10.32074\/1591-951X-1243_ref12","doi-asserted-by":"crossref","unstructured":"Knudsen ES, O\u2019Reilly EM, Brody JR, et al. Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine. Gastroenterology. 2016;150(1):48-63.https:\/\/doi.org\/10.1053\/j.gastro.2015.08.056","DOI":"10.1053\/j.gastro.2015.08.056"},{"key":"10.32074\/1591-951X-1243_ref13","doi-asserted-by":"crossref","unstructured":"Qian ZR, Rubinson DA, Nowak JA, et al. Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma. JAMA Oncol. 2019;5(4):579. https:\/\/doi.org\/10.1001\/jamaoncol.2019.0286","DOI":"10.1001\/jamaoncol.2017.3420"},{"key":"10.32074\/1591-951X-1243_ref14","doi-asserted-by":"crossref","unstructured":"Chapel DB, Schulte JJ, Berg K, et al. MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma. Mod Pathol. 2020;33(2):245-254. https:\/\/doi.org\/10.1038\/s41379-019-0310-0","DOI":"10.1038\/s41379-019-0310-0"},{"key":"10.32074\/1591-951X-1243_ref15","unstructured":"Illei PB, Rusch VW, Zakowski MF, et al. Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas. Clin Cancer Res. 2003;9(6):2108-2113."},{"key":"10.32074\/1591-951X-1243_ref16","doi-asserted-by":"crossref","unstructured":"Krasinskas AM, Bartlett DL, Cieply K, et al. CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survival. Mod Pathol. 2010;23(4):531-538. https:\/\/doi.org\/10.1038\/modpathol.2009.186","DOI":"10.1038\/modpathol.2009.186"},{"key":"10.32074\/1591-951X-1243_ref17","doi-asserted-by":"crossref","unstructured":"Yu S, Doyle LA, Hornick JL, et al. The diagnostic utility of methylthioadenosine phosphorylase immunohistochemistry for pancreatic ductal adenocarcinoma in FNA and small biopsy specimens. Cancer Cytopathol. 2024;132(2):87-95. https:\/\/doi.org\/10.1002\/cncy.22777","DOI":"10.1002\/cncy.22777"},{"key":"10.32074\/1591-951X-1243_ref18","doi-asserted-by":"crossref","unstructured":"Chung CT, Santo, G.daC, et al. FISH assay development for the detection of p16\/CDKN2A deletion in malignant pleural mesothelioma. J Clin Pathol. 2010;63(7), 630-634. https:\/\/doi.org\/10.1136\/jcp.2010.076794","DOI":"10.1136\/jcp.2010.076794"},{"key":"10.32074\/1591-951X-1243_ref19","doi-asserted-by":"crossref","unstructured":"Luc\u00e0 S, Pignata G, Cioce A, et al. Diagnostic Challenges in the Pathological Approach to Pleural Mesothelioma. Cancers. 2025;17(3), 481. https:\/\/doi.org\/10.3390\/cancers17030481","DOI":"10.3390\/cancers17030481"},{"key":"10.32074\/1591-951X-1243_ref20","doi-asserted-by":"crossref","unstructured":"Kinoshita Y, Hida T, Hamasaki M, et al. A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma. Cancer Cytopathol. 2018;126(1):54-63. https:\/\/doi.org\/10.1002\/cncy.21928","DOI":"10.1002\/cncy.21928"},{"key":"10.32074\/1591-951X-1243_ref21","doi-asserted-by":"crossref","unstructured":"Berg KB, Churg AM, Cheung S, et al. Usefulness of methylthioadenosine phosphorylase and BRCA-associated protein 1 immunohistochemistry in the diagnosis of malignant mesothelioma in effusion cytology specimens. Cancer Cytopathol. 2020:128(2);126-132. https:\/\/doi.org\/10.1002\/cncy.22221","DOI":"10.1002\/cncy.22221"},{"key":"10.32074\/1591-951X-1243_ref22","doi-asserted-by":"crossref","unstructured":"Sa-Ngiamwibool P, Hamasaki M, Kinoshita Y, et al. Challenges and limitation of MTAP immunohistochemistry in diagnosing desmoplastic mesothelioma\/sarcomatoid pleural mesothelioma with desmoplastic features. Ann Diagn Pathol. 2022:60,152004. https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.152004","DOI":"10.1016\/j.anndiagpath.2022.152004"},{"key":"10.32074\/1591-951X-1243_ref23","doi-asserted-by":"crossref","unstructured":"Chapel DB, Hornick JL, Barlow J, et al. Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma. Mod Pathol. 2022:35(10);1383-1397. https:\/\/doi.org\/10.1038\/s41379-022-01081-z","DOI":"10.1038\/s41379-022-01081-z"},{"key":"10.32074\/1591-951X-1243_ref24","doi-asserted-by":"crossref","unstructured":"Hwang H., Pyott S, Rodriguez S, et al. BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas. Am J Surg Pathol. 2016:40(5);714-718. https:\/\/doi.org\/10.1097\/PAS.0000000000000616","DOI":"10.1097\/PAS.0000000000000616"},{"key":"10.32074\/1591-951X-1243_ref25","doi-asserted-by":"crossref","unstructured":"Berg KB, Dacic S, Miller C, et al. Utility of Methylthioadenosine Phosphorylase Compared With BAP1 Immunohistochemistry, and CDKN2A and NF2 Fluorescence In Situ Hybridization in Separating Reactive Mesothelial Proliferations From Epithelioid Malignant Mesotheliomas. Arch Pathol Lab Med. 2018:142(12);1549-1553. https:\/\/doi.org\/10.5858\/arpa.2018-0273-OA","DOI":"10.5858\/arpa.2018-0273-OA"},{"key":"10.32074\/1591-951X-1243_ref26","doi-asserted-by":"crossref","unstructured":"McGregor SM, McElherne J, Minor A, et al. BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma. Hum Pathol. 2017:60;86-94. https:\/\/doi.org\/10.1016\/j.humpath.2016.09.026","DOI":"10.1016\/j.humpath.2016.09.026"},{"key":"10.32074\/1591-951X-1243_ref27","doi-asserted-by":"crossref","unstructured":"Hida T, Hamasaki M, Matsumoto S, et al. Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry. Lung Cancer. 2017:104;98-105. https:\/\/doi.org\/10.1016\/j.lungcan.2016.12.017","DOI":"10.1016\/j.lungcan.2016.12.017"},{"key":"10.32074\/1591-951X-1243_ref28","doi-asserted-by":"crossref","unstructured":"Kinoshita Y, Hamasaki M, Yoshimura M, et al. A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis. Lung Cancer. 2018:125;198-204. https:\/\/doi.org\/10.1016\/j.lungcan.2018.09.019","DOI":"10.1016\/j.lungcan.2018.09.019"},{"key":"10.32074\/1591-951X-1243_ref29","doi-asserted-by":"crossref","unstructured":"Wu D, Hiroshima K, Yusa T, et al. Usefulness of p16\/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma. Ann Diagn Pathol. 2017:26;31-37. https:\/\/doi.org\/10.1016\/j.anndiagpath.2016.10.010","DOI":"10.1016\/j.anndiagpath.2016.10.010"},{"key":"10.32074\/1591-951X-1243_ref30","doi-asserted-by":"crossref","unstructured":"Hustinx SR, Hruban RH, Leoni LM, et al. Homozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: a potential new target for therapy. Cancer Biol Ther. 2005:4(1);83-86. https:\/\/doi.org\/10.4161\/cbt.4.1.1380","DOI":"10.4161\/cbt.4.1.1380"},{"key":"10.32074\/1591-951X-1243_ref31","doi-asserted-by":"crossref","unstructured":"Deng H, Shi J, Wilkerson M, et al. Usefulness of S100P in diagnosis of adenocarcinoma of pancreas on fine-needle aspiration biopsy specimens. Am J Clin Pathol. 2008:129(1);81-88. https:\/\/doi.org\/10.1309\/5D76NDE81LE8G545","DOI":"10.1309\/5D76NDE81LE8G545"},{"key":"10.32074\/1591-951X-1243_ref32","doi-asserted-by":"crossref","unstructured":"Dim DC, Jiang F, Qiu Q, et al. The usefulness of S100P, mesothelin, fascin, prostate stem cell antigen, and 14-3-3 sigma in diagnosing pancreatic adenocarcinoma in cytological specimens obtained by endoscopic ultrasound guided fine-needle aspiration. Diagn Cytopathol. 2014:42(3);193-199. https:\/\/doi.org\/10.1002\/dc.21684","DOI":"10.1002\/dc.21684"},{"key":"10.32074\/1591-951X-1243_ref33","doi-asserted-by":"crossref","unstructured":"Aksoy-Altinboga A, Baglan T, Umudum H, et al. Diagnostic Value of S100p, IMP3, Maspin, and pVHL in the Differantial Diagnosis of Pancreatic Ductal Adenocarcinoma and Normal\/chronic Pancreatitis in Fine Needle Aspiration Biopsy. J Cytol. 2018:35(4);247-251. https:\/\/doi.org\/10.4103\/JOC.JOC18_17","DOI":"10.4103\/JOC.JOC_18_17"},{"key":"10.32074\/1591-951X-1243_ref34","doi-asserted-by":"crossref","unstructured":"Ali A, Brown V, Denley S, et al. Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panel. BMC Clin Pathol. 2014:14,35. https:\/\/doi.org\/10.1186\/1472-6890-14-35","DOI":"10.1186\/1472-6890-14-35"},{"key":"10.32074\/1591-951X-1243_ref35","doi-asserted-by":"crossref","unstructured":"Hu H, Zhang Q, Huang C, et al. Diagnostic value of S100P for pancreatic cancer: a meta-analysis. Tumor Biol. 2014:35(10);9479-9485. https:\/\/doi.org\/10.1007\/s13277-014-2461-4","DOI":"10.1007\/s13277-014-2461-4"},{"key":"10.32074\/1591-951X-1243_ref36","doi-asserted-by":"crossref","unstructured":"Sanchez-Vega F, Mina M, Armenia J, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell. 2018:173(2);321-337.e10. https:\/\/doi.org\/10.1016\/j.cell.2018.03.035","DOI":"10.1016\/j.cell.2018.03.035"},{"key":"10.32074\/1591-951X-1243_ref37","doi-asserted-by":"crossref","unstructured":"Schmid M, Malicki D, Nobori T, et al. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC). Oncogene. 1998:17(20);2669-2675. https:\/\/doi.org\/10.1038\/sj.onc.1202205","DOI":"10.1038\/sj.onc.1202205"},{"key":"10.32074\/1591-951X-1243_ref38","doi-asserted-by":"crossref","unstructured":"Dreyling MH, Roulston D, Bohlander SK, et al. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin\u2019s lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma. Genes Chromosomes Cancer. 1998:22(1);72-78.","DOI":"10.1002\/(SICI)1098-2264(199805)22:1<72::AID-GCC10>3.3.CO;2-G"},{"key":"10.32074\/1591-951X-1243_ref39","doi-asserted-by":"crossref","unstructured":"Vrugt B, Kirschner MB, Meerang M, et al. Deletions of CDKN2A and MTAP Detected by Copy-Number Variation Array Are Associated with Loss of p16 and MTAP Protein in Pleural Mesothelioma. Cancers. 2023:15(20),4978. https:\/\/doi.org\/10.3390\/cancers15204978","DOI":"10.3390\/cancers15204978"},{"key":"10.32074\/1591-951X-1243_ref40","doi-asserted-by":"crossref","unstructured":"Schmid M, Sen M, Rosenbach MD, et al. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer. Oncogene. 2000:19(50);5747-5754. https:\/\/doi.org\/10.1038\/sj.onc.1203942","DOI":"10.1038\/sj.onc.1203942"},{"key":"10.32074\/1591-951X-1243_ref41","doi-asserted-by":"crossref","unstructured":"Fraz\u00e3o L, do Carmo Martins M, Nunes VM, et al. BRAF V600E mutation and 9p21: CDKN2A\/B and MTAP co-deletions - Markers in the clinical stratification of pediatric gliomas. BMC Cancer. 2018:18(1):1259. https:\/\/doi.org\/10.1186\/s12885-018-5120-0","DOI":"10.1186\/s12885-018-5120-0"},{"key":"10.32074\/1591-951X-1243_ref42","doi-asserted-by":"crossref","unstructured":"Barekatain Y, Ackroyd JJ, Yan VC, et al. Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine. Nat Commun. 2021:12(1):4228. https:\/\/doi.org\/10.1038\/s41467-021-24240-3","DOI":"10.1158\/1538-7445.AM2022-2395"},{"key":"10.32074\/1591-951X-1243_ref43","doi-asserted-by":"crossref","unstructured":"Suzuki T, Maruno M, Wada K, et al. Genetic analysis of human glioblastomas using a genomic microarray system. Brain Tumor Pathol. 2004:21(1);27-34. https:\/\/doi.org\/10.1007\/BF02482174","DOI":"10.1007\/BF02482174"},{"key":"10.32074\/1591-951X-1243_ref44","doi-asserted-by":"crossref","unstructured":"Dudley JC, Zheng Z, McDonald T, et al. Next-Generation Sequencing and Fluorescence in Situ Hybridization Have Comparable Performance Characteristics in the Analysis of Pancreaticobiliary Brushings for Malignancy. J Mol Diagn. 2016;18(1):124-130. https:\/\/doi.org\/10.1016\/j.jmoldx.2015.08.002","DOI":"10.1016\/j.jmoldx.2015.08.002"},{"key":"10.32074\/1591-951X-1243_ref45","doi-asserted-by":"crossref","unstructured":"Layfield L. Role of Ancillary Techniques in Biliary Cytopathology Specimens. Acta Cytol. 2020;64(1-2):175-181. https:\/\/doi.org\/10.1159\/000498976","DOI":"10.1159\/000498976"},{"key":"10.32074\/1591-951X-1243_ref46","doi-asserted-by":"crossref","unstructured":"Hilburn CF, Pitman MB. The Cytomorphologic and Molecular Assessment of Bile Duct Brushing Specimens. Surg Pathol Clin. 2022;15(3):469-478. https:\/\/doi.org\/10.1016\/j.path.2022.05.002","DOI":"10.1016\/j.path.2022.05.002"},{"key":"10.32074\/1591-951X-1243_ref47","doi-asserted-by":"crossref","unstructured":"Scheid JF, Rosenbaum MW, Przybyszewski EM, et al. Next-generation sequencing in the evaluation of biliary strictures in patients with primary sclerosing cholangitis. Cancer Cytopathol. 2022;130(3):215-230. https:\/\/doi.org\/10.1002\/cncy.22528","DOI":"10.1002\/cncy.22528"},{"key":"10.32074\/1591-951X-1243_ref48","doi-asserted-by":"crossref","unstructured":"Minca EC, Lanigan CP, Reynolds JP, et al. ALK status testing in non-small-cell lung carcinoma by FISH on ThinPrep slides with cytology material. J Thorac Oncol. 2014;9(4):464-468. https:\/\/doi.org\/10.1097\/JTO.0000000000000104","DOI":"10.1097\/JTO.0000000000000104"},{"key":"10.32074\/1591-951X-1243_ref49","unstructured":"Ashok V, Ranganathan R, Chander S, et al. Comparison of Diagnostic Yield of a FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases. Asian Pac J Cancer Prev. 2017;18(12):3457-3464. https:\/\/doi.org\/10.22034\/APJCP.2017.18.12.3457"},{"key":"10.32074\/1591-951X-1243_ref50","doi-asserted-by":"crossref","unstructured":"Fink JL, Jaradi B, Stone N, et al. Minimizing Sample Failure Rates for Challenging Clinical Tumor Samples. J Mol Diagn. 2023;25(5), 263-273. https:\/\/doi.org\/10.1016\/j.jmoldx.2023.01.008","DOI":"10.1016\/j.jmoldx.2023.01.008"},{"key":"10.32074\/1591-951X-1243_ref51","doi-asserted-by":"crossref","unstructured":"Gorbokon N, Teljuk K, Reiswich V, et al. Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal Adenocarcinomas. Cancers (Basel). 2025;17(7):1205. Published 2025 Apr 1. https:\/\/doi.org\/10.3390\/cancers17071205","DOI":"10.3390\/cancers17071205"},{"key":"10.32074\/1591-951X-1243_ref52","doi-asserted-by":"crossref","unstructured":"Fan N, Zhang Y, Zou S. Methylthioadenosine phosphorylase deficiency in tumors: A compelling therapeutic target. Front Cell Dev Biol. 2023;11:1173356. Published 2023 Apr 5. https:\/\/doi.org\/10.3389\/fcell.2023.1173356","DOI":"10.3389\/fcell.2023.1173356"},{"key":"10.32074\/1591-951X-1243_ref53","doi-asserted-by":"crossref","unstructured":"Subhi AL, Tang B, Balsara BR, et al. Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancer. Clin Cancer Res. 2004;10(21):7290-7296. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0972","DOI":"10.1158\/1078-0432.CCR-04-0972"},{"key":"10.32074\/1591-951X-1243_ref54","doi-asserted-by":"crossref","unstructured":"Hu Q, Qin Y, Ji S, et al. MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Glycolysis in Pancreatic Cancer. Cancer Res. 2021;81(19):4964-4980. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-0414","DOI":"10.1158\/0008-5472.CAN-20-0414"},{"key":"10.32074\/1591-951X-1243_ref55","doi-asserted-by":"crossref","unstructured":"Mavrakis KJ, McDonald ER 3rd, Schlabach MR, et al. Disordered methionine metabolism in MTAP\/CDKN2A-deleted cancers leads to dependence on PRMT5. Science. 2016;351(6278):1208-1213. https:\/\/doi.org\/10.1126\/science.aad5944","DOI":"10.1126\/science.aad5944"},{"key":"10.32074\/1591-951X-1243_ref56","doi-asserted-by":"crossref","unstructured":"Driehuis E, van Hoeck A, Moore K, et al. Pancreatic cancer organoids recapitulate disease and allow personalized drug screening. Proc Natl Acad Sci U S A. 2019;116(52):26580-26590. https:\/\/doi.org\/10.1073\/pnas.1911273116","DOI":"10.1073\/pnas.1911273116"}],"container-title":["Pathologica"],"original-title":[],"link":[{"URL":"https:\/\/www.pathologica.it\/article\/view\/1243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T11:47:54Z","timestamp":1766836074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.pathologica.it\/article\/view\/1243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":56,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10]]}},"URL":"https:\/\/doi.org\/10.32074\/1591-951x-1243","relation":{},"ISSN":["1591-951X"],"issn-type":[{"value":"1591-951X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"article-number":"4"}}